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Background
Heart Failure (HF) is the most common cause of death in
Friedreich’s ataxia (FRDA), a mitochondrial disease char-
acterized by neurodegeneration, hypertrophic cardiomyo-
pathy, caused by homozygous GAA expansions in the
FXN gene. Recent report demonstrates that specific-gene
therapy may prevent and reverse the cardiomyopathy in a
mice model of FRDA. Myocardial interstitial fibrosis is a
hallmark of FRDA’s cardiomyopathy and a potential sub-
strate for arrhythmias and HF. Myocardial tissue charac-
terization by cardiac magnetic resonance (CMR) allows
access to tissue-based phenotypes that may better describe
LV remodeling in FRDA’s cardiomyopathy.
Methods
The aim of this study was to perform direct quantification
of myocardial extracellular volume fraction (ECV) and
intracellular lifetime of water (τic), a measure of cardio-
myocyte hypertrophy, using T1-weighted CMR imaging in
cohort of patients with FRDA without HF.
We investigated 27 FRDA patients without HF (mean
age 26.8 ± 9, 12 female) and in 30 healthy volunteers as
control subjects (mean age 49 ± 15) using a 3T CMR sys-
tem. The T1 quantification by Look-Locker gradient-echo
before and after contrast applying a 2-site model for trans-
cytolemmal water Exchange was used for ECV and τic
quantification. Cine CMR and LGE imaging in matching
locations were also performed.
Results
FRDA patients revealed normal LVEF with increased LV
Mass-index compared with health controls (for LVEF
67.3% ± 11.5 vs. 62.5% ± 6.8, P = NS; for LVMASSi 62.7 ±
23 vs. 45.1 ± 6.8 g/m2, p < 0.05). In 4 out 27 FRDA
patients a non-ischemic LGE pattern was present. Both
ECV and intracellular lifetime of water (τic) were signifi-
cantly higher FRDA patients (ECV: 0.36 ± 0.04 vs. 0.28 ±
0.03, p < 0.0001; τic: 0.12 ± 0.08 vs. 0.08 ± 0.03, p < 0.005).
Conclusions
ECV and intracellular lifetime of water (τic) determined by
T1 measurements characterized early signs of myocardial
tissue remodeling in FRDA with normal LVEF. Early
changes in tissue-phenotypes are detectable by novel-CMR
methods in FRDA patients, and may be useful to track
effects of new genetic therapies for FRDA cardiomyopathy.
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